Shalby Limited Stock: price and insider trades · India
1 insider bought €6,905 of shares over the last 90 days, the latest by VIKRAM INDRAJIT SHAH, filed 21 Aug 2026.
Shalby Limited: what insiders have been doing
Every trade that managers of Shalby Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 28 October 2026, 1 filing were filed, from 1 insider.
The flow runs one way only: 1 insider bought (1 purchase totalling €6,905) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Vikram Indrajit Shah filed the largest purchase, €6,905, on 21 August 2026, which represents 0.0047% of the company's market value. The buyers include 1 senior executive.
For context, the typical company on the same exchange (median of 1,893 companies) published 4 filings over the same period, against 1 filing here. Looking back to 2021, when coverage begins, insiders filed 11 purchases and 2 sales.
The latest purchase dates back some time: it was published 79 days ago, on 21 August 2026.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -25.2%Entry ₹154.10 · Close 22 Oct 2026 ₹115.19
- +4.8%Entry ₹213.00 · Close at T+365 ₹223.22
- -15.1%Entry ₹238.95 · Close at T+365 ₹202.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 5,000 shares@ ₹154.700.0047% mcap100.0% of flowEquityMarket PurchaseSEBI:7b175d9ad89fae68eb3be9462fa29a18034c6f2eCanonical exit: 19 Nov 2026 (T+90)
- 60,000 sharesEquity SharesSEBI:2b19afeeb8848e4bc45c1e01d4b14f9b600f8981Canonical exit: 18 Dec 2025 (T+90)
- 25,000 shares@ ₹218.195568.6% of flowEquity SharesSEBI:ba5ac0cb711d0fa5894bc8db9f600cb0bfad6161Canonical exit: 12 Feb 2025 (T+90)
- 10,000 shares@ ₹254.160431.4% of flowEquity SharesSEBI:acba09026e634600b324714da4781afb7c45ff42Canonical exit: 3 Sept 2024 (T+90)
- 125,000 shares@ ₹244.200566.5% of flowEquity SharesSEBI:e24fcb4f135784ead4aaef2472c042edb0c2e884Canonical exit: 4 Jun 2024 (T+90)
- 30,000 shares@ ₹149.634710.2% of flowEquity SharesSEBI:ecc518894435fc185e1181c2e5bf3dbb6af16bdcCanonical exit: 7 Mar 2023 (T+90)
- 20,000 shares@ ₹151.66837.0% of flowEquity SharesSEBI:21e351329c315387f7dfe1743809e66809ec5e47Canonical exit: 26 Feb 2023 (T+90)
- 20,000 shares@ ₹143.50776.7% of flowEquity SharesSEBI:7642bb50a4fc5b49b0d6168875fa09b87a66780bCanonical exit: 13 Feb 2023 (T+90)
- 20,000 shares@ ₹144.88417.0% of flowEquity SharesSEBI:4f4d4c0ba2a5b53fcd043280366dac6de273628cCanonical exit: 1 Feb 2023 (T+90)
- 530 shares@ ₹145.1302100.0% of flowEquity SharesSEBI:7ee84abdd4e74af122681650952fe4f493893407
- 10,000 shares@ ₹111.27172.6% of flowEquity SharesSEBI:2d3984eb3bffdfc554809d9646c64f8765899da8Canonical exit: 29 Aug 2022 (T+90)
- 700,000 shares@ ₹107.7548100.0% of flowEquity SharesSEBI:854d7c607f5180a988c1f850b84097dca316c7c8Canonical exit: 28 Aug 2022 (T+90)
- 57,306 shares@ ₹188.74660.080% mcap100.0% of flowEquity SharesSEBI:484ae4db3d957fe994678cf03cc6d8c49d47f0f1
13 of 13 declarations
About Shalby Limited
Shalby Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
